First patient dosed marks an important step for the SMA community and highlights a growing rare disease manufacturing ...
Regulators have approved the first drug that targets the muscle in spinal muscular atrophy, after children gained motor function in trials. The post First Drug to Target the Muscle in Spinal Muscular ...
The FDA has approved Isembyld, the first and only treatment to demonstrate motor function improvement in individuals with ...
In what signifies the end of a challenging regulatory journey, Scholar Rock secured an FDA approval for its spinal muscular ...
If you’ve wondered if spinal muscular atrophy is the same as spina bifida, you aren’t alone. It’s easy to confuse these two conditions since they both involve the spine. But spinal muscular atrophy ...
Scholar Rock Holding ( SRRK) surged 12% in extended trading Friday after the Food and Drug Administration approved isembyld, ...
FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a ...
MedPage Today on MSN
First therapy to target muscle loss in spinal muscular atrophy gets FDA approval
Motor function may improve with adjunctive apitegromab ...
The discovery could help scientists advance research into conditions including Amyotrophic lateral sclerosis (ALS), also ...
You might not think of diabetes when you think of muscle function. But a common diabetes drug that regulates blood sugar can also prevent muscle atrophy and muscular fibrosis—which can help the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results